Cargando…

Drug Repurposing for Glioblastoma and Current Advances in Drug Delivery—A Comprehensive Review of the Literature

Glioblastoma (GBM) is the most common primary malignant brain tumor in adults with an extremely poor prognosis. There is a dire need to develop effective therapeutics to overcome the intrinsic and acquired resistance of GBM to current therapies. The process of developing novel anti-neoplastic drugs...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alomari, Safwan, Zhang, Irma, Hernandez, Adrian, Kraft, Caitlin Y., Raj, Divyaansh, Kedda, Jayanidhi, Tyler, Betty
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8699739/ https://www.ncbi.nlm.nih.gov/pubmed/34944514 http://dx.doi.org/10.3390/biom11121870

Ejemplares similares

The Neurodevelopmental and Molecular Landscape of Medulloblastoma Subgroups: Current Targets and the Potential for Combined Therapies
por: Slika, Hasan, et al.
Publicado: (2023)

Crossing the Blood-Brain Barrier: Advances in Nanoparticle Technology for Drug Delivery in Neuro-Oncology
por: Hersh, Andrew M., et al.
Publicado: (2022)

Preclinical Models and Technologies in Glioblastoma Research: Evolution, Current State, and Future Avenues
por: Slika, Hasan, et al.
Publicado: (2023)

Drug repurposing for the treatment of glioblastoma multiforme
por: Abbruzzese, Claudia, et al.
Publicado: (2017)

Molecular Pathways and Genomic Landscape of Glioblastoma Stem Cells: Opportunities for Targeted Therapy
por: Hersh, Andrew M., et al.
Publicado: (2022)

Metabolic modeling-based drug repurposing in Glioblastoma
por: Tomi-Andrino, Claudio, et al.
Publicado: (2022)

From GWAS to drug screening: repurposing antipsychotics for glioblastoma
por: Lin, Wei-Zhi, et al.
Publicado: (2022)

An Alternative Pipeline for Glioblastoma Therapeutics: A Systematic Review of Drug Repurposing in Glioblastoma
por: Lyne, Seán B., et al.
Publicado: (2021)

Applications of Focused Ultrasound for the Treatment of Glioblastoma: A New Frontier
por: Hersh, Andrew M., et al.
Publicado: (2022)

Current Perspective on the Natural Compounds and Drug Delivery Techniques in Glioblastoma Multiforme
por: Behl, Tapan, et al.
Publicado: (2021)

Drug repurposing using transcriptome sequencing and virtual drug screening in a patient with glioblastoma
por: Saeed, Mohamed E. M., et al.
Publicado: (2020)

Current Drug Repurposing Strategies for Rare Neurodegenerative Disorders
por: Shah, Sweta, et al.
Publicado: (2021)

Drug Delivery Nanosystems in Glioblastoma Multiforme Treatment: Current State of the Art
por: Di Filippo, Leonardo Delello, et al.
Publicado: (2021)

Developments in Blood-Brain Barrier Penetrance and Drug Repurposing for Improved Treatment of Glioblastoma
por: Harder, Bryan G., et al.
Publicado: (2018)

Drug Repurposing, a Fast-Track Approach to Develop Effective Treatments for Glioblastoma
por: Ntafoulis, Ioannis, et al.
Publicado: (2022)

Nanomedicine for Gene Delivery and Drug Repurposing in the Treatment of Muscular Dystrophies
por: Andreana, Ilaria, et al.
Publicado: (2021)

Dendrimer Technology in Glioma: Functional Design and Potential Applications
por: Gaitsch, Hallie, et al.
Publicado: (2023)

Exploration of databases and methods supporting drug repurposing: a comprehensive survey
por: Tanoli, Ziaurrehman, et al.
Publicado: (2020)

Nanoscale Drug Delivery Systems in Glioblastoma
por: Liu, Zihao, et al.
Publicado: (2022)

Editorial: Drug Repurposing
por: Pantziarka, Pan, et al.
Publicado: (2019)

Antifungal Drug Repurposing
por: Kim, Jong H., et al.
Publicado: (2020)

Drug repurposing in cardiology
por: van Driel, B. O., et al.
Publicado: (2020)

Drug repurposing approach to fight COVID-19
por: Singh, Thakur Uttam, et al.
Publicado: (2020)

Repurposing of antiviral drugs for COVID-19 and impact of repurposed drugs on the nervous system
por: Punekar, Madhura, et al.
Publicado: (2022)

Blocking epithelial-to-mesenchymal transition in glioblastoma with a sextet of repurposed drugs: the EIS regimen
por: Kast, Richard E, et al.
Publicado: (2017)

Tackling the Behavior of Cancer Cells: Molecular Bases for Repurposing Antipsychotic Drugs in the Treatment of Glioblastoma
por: Persico, Michele, et al.
Publicado: (2022)

Repurposing FDA-approved drugs as inhibitors of therapy-induced invadopodia activity in glioblastoma cells
por: Jones, Dylan, et al.
Publicado: (2022)

Drug Delivery Nanosystems for the Localized Treatment of Glioblastoma Multiforme
por: Nam, L., et al.
Publicado: (2018)

Enhancing the anticancer immune response with the assistance of drug repurposing and delivery systems
por: Fu, Zile, et al.
Publicado: (2023)

Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
por: Sadeghi, Hosna Mohammad, et al.
Publicado: (2022)

Drug Repurposing for Schistosomiasis: Combinations of Drugs or Biomolecules
por: Gouveia, Maria João, et al.
Publicado: (2018)

Drug Repurposing for the Management of Depression: Where Do We Stand Currently?
por: Mohammad Sadeghi, Hosna, et al.
Publicado: (2021)

Targeting Mast Cells in Allergic Disease: Current Therapies and Drug Repurposing
por: Burchett, Jason R., et al.
Publicado: (2022)

Local Drug Delivery Strategies for Glioblastoma Treatment
por: Cha, Gi Doo, et al.
Publicado: (2022)

Editorial: Drug repurposing and polypharmacology: A synergistic approach in multi-target based drug discovery
por: Rudrapal, Mithun, et al.
Publicado: (2022)

Repurposing of approved cardiovascular drugs
por: Ishida, Junichi, et al.
Publicado: (2016)

Drug repurposing with network reinforcement
por: Nam, Yonghyun, et al.
Publicado: (2019)

Repurposed Drugs in Gastric Cancer
por: Araújo, Diana, et al.
Publicado: (2022)

Drug Repurposing for Triple-Negative Breast Cancer
por: Ávalos-Moreno, Marta, et al.
Publicado: (2020)

New and repurposed drugs to treat multidrug- and extensively drug-resistant tuberculosis
por: Silva, Denise Rossato, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_2tmvcmvggsbma2m7sv1ga655ip